Can Lower-Risk MDS Achieve High Reward with Hypomethylating Agent Therapy?
Journal article published in 2022 by
Rafael Bejar
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 